Hydroxysteroid 17-Beta Dehydrogenase 13 (HSD17B13) A GWAS study using a total of 37,173 patients identified a highly significant association between a splice variant (rs72613567:TA) in HSD17B13 with reduced levels of ALT and AST, and a reduced risk for NASH [ 43 ].
← all excerpts
Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma.
1
—
—